Back
HFA Premium Access

HFWM: Complex effects of the myosin activator omecamtiv mecarbil on cardiac contractility

Session: Poster Session 3 - Basic Science: Drug therapy, other
Topic: Drug therapy, other
Speaker: Professor F. Levy (Oslo, NO)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Finn Olav Levy

University of Oslo, Oslo (Norway)
0 follower

3 more presentations in this session

Comparative bioenergetic effects of levosimendan and omecamtiv mecarbil in guinea-pig cardiac myocytes

Speaker: Miss D. Puetz (Homburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Circulating blood levels of growth differentiation factor 11 are decreased in dogs with heart failure and restored after long-term therapy with elamipretide (Bendavia, MTP-131)

Speaker: Professor H. Sabbah (Detroit, US)

Access
Abstract
Slides
Like
Thumbnail

Trimetazidine effects on the quality of life of women with chronic heart failure

Speaker: Doctor N. Koriagina (Perm, RU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Basic Science: Drug therapy, other

Speakers: Professor F. Levy, Miss D. Puetz, Professor H. Sabbah, Doctor N. Koriagina
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources